Elizabeth Christopher

Elizabeth Christopher, MBA, currently serves as Associate Director at ImmunoGen, Inc., a position held since March 2022, following a role as Senior Clinical Trial Manager at Gritstone Oncology from March 2021 to March 2022. Previous experience includes Global Clinical Studies Manager at Parker Institute for Cancer Immunotherapy, Clinical Trial Manager roles at CymaBay Therapeutics, and multiple positions with Syneos Health, NYU Langone Medical Center, Weill Cornell Medical College, and Mount Sinai Medical Center, focusing on various aspects of clinical research and trials. Elizabeth holds an MBA from Fordham Gabelli School of Business and a BS in Biology from St. John's University.